FOR THE LIFE SCIENCES INDUSTRY

9:45  EPHEMERAL MESSAGING

Life Sciences and the Continuing Compliance Challenges of Ephemeral Messaging: DOJ’s Increasing Oversight and How to Resolve the Most Complex Dilemmas

How are life sciences companies reviewing ephemeral business communications policies and procedures, as well as emerging privacy, security, and employment law scrutiny?

Don’t miss this critically important session as we discuss:

• The new expectations for retaining business records and correspondence

• Data privacy issues that can affect compliance with DOJ data retention policies

• How the life sciences industry is updating messaging app policies, procedures, and monitoring

• When to restrict use of messaging apps to company-owned

• The three biggest ephemeral messaging dilemmas for life sciences:

» Mitigating WeChat messaging and document sharing and retention risks when operating in China

» Reviewing data privacy policies and regulations: Ensuring that all business communications can be reviewed in high-risk jurisdictions like China, Latin America, and India

» Implementing internal investigations practices for data localization, collection, and review

10:45  Extended Networking Break

Rebecca Orttel Vice President, Ethics and Compliance Medtronic

Lisa LeCointe-Cephas Senior Vice President - Chief Ethics & Compliance Officer Merck & Co.

Matt Werner Vice President, Chief Compliance & Privacy Officer Bio-Rad Laboratories, Inc.